Xact OMXS30 vs UBS Lux Equity Fund Biotech USD

Xact OMXS30 vs UBS Lux Equity Fund Biotech USD

1. Xact OMXS30

  • Security

    Xact OMXS30 ESG ETF

  • Fee

    0.10%

  • ISIN

    SE0000693293

  • Holdings

    25

  • Number of owning funds

    1

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

Fund Holdings

We have information about 33 holdings in Xact OMXS30, where the largest holding is Atlas Copco (10.49), followed by Investor (9.67) and Volvo (8.17). In comparison with UBS Lux Equity Fund Biotech USD, we have 7 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66).

All Holdings

Here we compare the holdings in Xact OMXS30 and UBS Lux Equity Fund Biotech USD.

Xact OMXS30 UBS Lux Equity Fund Biotech USD
1. Atlas Copco A
Sweden
10.49 %		 1. Regeneron Pharmaceuticals Inc
10.04 %
2. Investor B
Sweden
9.67 %		 2. Moderna Inc
9.21 %
3. Volvo B
Sweden
8.17 %		 3. Gilead Sciences Inc
USA
4.66 %
4. Assa Abloy B
Sweden
6.03 %		 4. BioNTech SE
4.13 %
5. Hexagon B
Sweden
5.64 %		 5. Karuna Therapeutics Inc
3.75 %
6. SEB A
Sweden
5.57 %		 -
7. Sandvik
Sweden
4.84 %		 -
8. Swedbank A
Sweden
4.59 %		 -
9. ABB Ltd
Sweden Switzerland
4.53 %		 -
10. Atlas Copco B
Sweden
4.34 %		 -
11. Ericsson B
Sweden
4.34 %		 -
12. AstraZeneca
Sweden UK
4.04 %		 -
13. Handelsbanken A
Sweden
4.01 %		 -
14. Hennes & Mauritz B
Sweden
3.52 %		 -
15. Alfa Laval
Sweden
3.44 %		 -
16. Essity B
Sweden
3.03 %		 -
17. Telia Company AB
Sweden
2.15 %		 -
18. SCA B
Sweden
1.64 %		 -
19. SKF B
Sweden
1.61 %		 -
20. Nordea Bank Abp
Finland
1.59 %		 -
21. Boliden AB
Sweden
1.53 %		 -
22. Tele2 B
Sweden
1.41 %		 -
23. NIBE Industrier B
Sweden
1.33 %		 -
24. Getinge B
Sweden
0.93 %		 -
25. Electrolux B
Sweden
0.47 %		 -

The list of fund holdings was last updated on September 10, 2025.